Dow Up 0.36% Nasdaq Up 0.12%

Agenus Inc. (AGEN)

-NasdaqCM
3.12 0.07(2.19%) Aug 21, 4:00PM EDT
Prev Close:3.19
Open:3.17
Bid:2.94 x 100
Ask:3.24 x 200
1y Target Est:5.75
Beta:2.23
Next Earnings Date:N/A
Day's Range:3.08 - 3.20
52wk Range:2.27 - 5.27
Volume:468,798
Avg Vol (3m):910,264
Market Cap:195.56M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 2.19%195.56M
ABPI224.39K
DNDN209.05M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback